BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11385709)

  • 1. Frequency of recent retrotransposition events in the human factor IX gene.
    Li X; Scaringe WA; Hill KA; Roberts S; Mengos A; Careri D; Pinto MT; Kasper CK; Sommer SS
    Hum Mutat; 2001 Jun; 17(6):511-9. PubMed ID: 11385709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel large F9 gene mutation-an insertion of an Alu repeated DNA element in exon e of the factor 9 gene.
    Wulff K; Gazda H; Schröder W; Robicka-Milewska R; Herrmann FH
    Hum Mutat; 2000 Mar; 15(3):299. PubMed ID: 10679958
    [No Abstract]   [Full Text] [Related]  

  • 3. Alu retrotransposition-mediated deletion.
    Callinan PA; Wang J; Herke SW; Garber RK; Liang P; Batzer MA
    J Mol Biol; 2005 May; 348(4):791-800. PubMed ID: 15843013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel human pathological mutations. Gene symbol: F9. Disease: Haemophilia B.
    Niazi G; Shaukat Z; Masood K; Hussain R
    Hum Genet; 2009 Aug; 126(2):332. PubMed ID: 19693996
    [No Abstract]   [Full Text] [Related]  

  • 5. Nine independent F9 mutations in the Mexican hemophilia B population: nonrandom recurrences of point mutation events in the human germline.
    Jaloma-Cruz AR; Scaringe WA; Drost JB; Roberts S; Li X; Barros-Núñez P; Figuera LE; Rivas F; Cantú JM; Sommer SS
    Hum Mutat; 2000 Jan; 15(1):116-7. PubMed ID: 10612837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the retrotransposition rate of human Alu elements.
    Cordaux R; Hedges DJ; Herke SW; Batzer MA
    Gene; 2006 May; 373():134-7. PubMed ID: 16522357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B.
    Nakamura Y; Murata M; Takagi Y; Kozuka T; Nakata Y; Hasebe R; Takagi A; Kitazawa J; Shima M; Kojima T
    Int J Hematol; 2015 Jul; 102(1):134-9. PubMed ID: 25739383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mutagenic B1 retrotransposon insertion in the jittery mouse.
    Gilbert N; Bomar JM; Burmeister M; Moran JV
    Hum Mutat; 2004 Jul; 24(1):9-13. PubMed ID: 15221784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the factor IX gene (F9) during the past 150 years have relative rates similar to ancient mutations.
    Feng J; Drost JB; Scaringe WA; Liu Q; Sommer SS
    Hum Mutat; 2002 Jan; 19(1):49-57. PubMed ID: 11754103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients.
    Mukherjee S; Mukhopadhyay A; Banerjee D; Chandak GR; Ray K
    Haemophilia; 2004 May; 10(3):259-63. PubMed ID: 15086324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Alu insertions on gene function.
    Szmulewicz MN; Novick GE; Herrera RJ
    Electrophoresis; 1998 Jun; 19(8-9):1260-4. PubMed ID: 9694261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions with inversions: report of a mutation and review of the literature.
    Ketterling RP; Ricke DO; Wurster MW; Sommer SS
    Hum Mutat; 1993; 2(1):53-7. PubMed ID: 8477264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype analysis of identical factor IX mutants using PCR.
    Green PM; Montandon AJ; Ljung R; Nilsson IM; Giannelli F
    Thromb Haemost; 1992 Jan; 67(1):66-9. PubMed ID: 1615486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recently integrated Alu elements and human genomic diversity.
    Salem AH; Kilroy GE; Watkins WS; Jorde LB; Batzer MA
    Mol Biol Evol; 2003 Aug; 20(8):1349-61. PubMed ID: 12777511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
    Matthews RJ; Anson DS; Peake IR; Bloom AL
    J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence correlation between neighboring Alu instances suggests post-retrotransposition sequence exchange due to Alu gene conversion.
    Zhi D
    Gene; 2007 Apr; 390(1-2):117-21. PubMed ID: 17134854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct mutations cause severe hemophilia B in two unrelated canine pedigrees.
    Gu W; Brooks M; Catalfamo J; Ray J; Ray K
    Thromb Haemost; 1999 Oct; 82(4):1270-5. PubMed ID: 10544912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.